Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Retatrutide's role in modern obesity and diabetes therapy
which can result in the following symptoms: swelling pain discoloration a rash To help manage any discomfort, you can try applying a cool compress or ice pack to the area to help reduce swelling
The mechanism worth understanding: Retatrutide delays gastric emptying by binding to GLP-1 receptors in the stomach and small intestine, which slows the rate at which food moves from the stomach to the duodenum
Nausea Vomiting Diarrhea Constipation Decreased appetite Injection-site reactions Gallbladder events (cholelithiasis, cholecystitis) reported in some Phase 2 participants Increased heart rate Possible pancreatitis (per GLP-1 class data not specifically reported in retatrutide trials) Frequently asked questions Is retatrutide FDA-approved
In addition, their impact on gastric motility has raised perioperative concerns, particularly related to delayed gastric emptying, which increases the risk of vomiting and aspiration during induction of general anesthesia
5f, quantification: Fig
